Ecrins Therapeutics

Ecrins Therapeutics is developing a wide-ranging portfolio of anti-cancer products. Our compounds target tumors by several different mechanisms and are intended for the treatment of a range of cancers. In particular, Ecrins Therapeutics’s pipeline includes small molecule inhibitors that target tumor vessels, effectively starving off cancer cells.